- MannKind Elder Abuse Is Replacing Inept CEO With Founder
- Has Obamacare Failed? 10 States With the Least Insurance Coverage
- Church Of Scientology Celebrates A Decade Of Expansion Under The Leadership Of David Miscavige
- Would a Mitt Romney Presidency Be Good for the FinTech Industry?
- DraftKings, FanDuel Players Fight Repayment of Credit-Card Bets
Stocks turned green by mid-afternoon as rising tensions between Russia and Turkey pushed crude oil higher.
11/24/15 - 04:45 PM EST
These stocks are little-known, but that won't last. Here's why you should scoop them up now, while they're still cheap and before they burst into the headlines.
11/24/15 - 12:03 PM EST
Wall Street sure loves these stocks! Do they merit your enthusiasm, as well? We look at the real numbers to see if the wild popularity of these equities is warranted.
11/24/15 - 11:48 AM EST
TheStreet's Jim Cramer answers viewer questions on Skyworks (SWKS), PMC-Sierra (PMCS), Avago Technologies (AVGO), Apple (AAPL), Allergan (AGN), Pfizer (PFE), Lockheed Martin (LMT), Hewlett Packard Enterprise (HPE) and more.
11/24/15 - 11:24 AM EST
By moving its new headquarters to Allergan's Ireland base, the new combined drug giant will likely save billions of dollars in taxes.
11/24/15 - 08:23 AM EST
Which health care companies are the most shareholder friendly? Pfizer, which agreed on Monday to merge with Allergan, is one of them. But what about the rest of the sector?
11/23/15 - 03:20 PM EST
TheStreet's Jim Cramer answers viewers' questions on Allergan, Pfizer, Disney, MasterCard, Chipotle, Under Armour and more.
11/23/15 - 11:46 AM EST
Stocks moved higher in midday trading Monday, though cautiously after stellar gains last week marked the S&P 500's best five-day period of the year so far.
11/23/15 - 11:56 AM EST
U.S. stocks opened slightly lower as Wall Street digests one of the largest mergers in history.
11/23/15 - 10:01 AM EST
Which health care stocks are both alluring - when it comes to rapid advances in new technology or a cure for a disease - but also sound investments?
11/21/15 - 02:00 PM EST
Shares of biotech stocks have been volatile this year, but the sector is still outperforming the broader markets. Here's JPMorgan's top biotech picks coming out of earnings season.
11/21/15 - 01:15 PM EST
Jim Cramer, portfolio manager of the TheStreet's Action Alerts PLUS, said based on valuation investors should buy Allergan over Pfizer.
11/20/15 - 03:10 PM EST